AdJane Unveils Mucosal Booster Strategy for Next-Generation Respiratory Vaccine Franchises

Summary

AdJane Biosciences unveiled a mucosal booster strategy for respiratory vaccines using its clinically validated Nm-nOMV platform in a white paper. The platform could be added as a proprietary mucosal component to existing intramuscular vaccination programs.